Neuromodulation system and method with feedback optimized electrical field generation
A neuromodulation system and method with feedback optimized electrical field generation for stimulating target tissue of a patient to treat neurological and non-neurological conditions. The system generally includes implantable electrodes, implantable sensors, an implantable or external electrical signal generator, and an implantable or external controller. The controller controls the electrical signal generator to generate electrical noise stimulation signals that are delivered to the target tissue via the electrodes and that produce an optimized electric field having maximized voltage with low current density. The sensors produce temperature and impedance data for the target tissue and the controller automatically responds to values of the sensor data that indicate potential damage to the target tissue to reduce the strength of the electric field.
1. A system, comprising:
an electrical signal generator adapted to generate an electrical noise stimulation signal;
an implantable electrode adapted to receive the electrical noise stimulation signal and to produce an electric field for application to a target tissue;
a temperature sensor adapted to be implantable in or near the target tissue, wherein the temperature sensor is configured to generate a temperature data indicative of a temperature associated with the target tissue in response to application of the electric field to the target tissue;
a controller in communication with the electrical signal generator and the temperature sensor, wherein the controller is configured to:
receive the temperature data; and
automatically control the electrical signal generator in response to the temperature data to generate the electrical noise stimulation signal to optimize the electric field to produce a therapeutic effect without the temperature data indicating potential damage to the target tissue by the electrical noise stimulation signal;
wherein the temperature data varies in relation to a level of current density produced by the electric field in the target tissue and wherein optimization of the electric field includes delivering the level of current density that corresponds to a range of temperatures previously determined not to cause damage to the target tissue.
2. The system of claim 1 , wherein the electrical signal generator is adapted to be implantable.
3. The system of claim 1 , wherein the controller is configured to respond to the temperature data indicating the temperature is associated with potential damage to the target tissue by automatically reducing a strength of the electric field.
4. The system of claim 3 , wherein the controller is configured to respond to the temperature data indicating the temperature is associated with potential damage to the target tissue by automatically reducing a current density or a current flow of the electric field.
5. The system of claim 1 , wherein the controller is configured to control the electrical signal generator to limit a dose of the electric field to produce the therapeutic effect.
6. The system of claim 1 , wherein the controller is configured to control the electrical signal generator to optimize the electric field by maximizing a voltage of the electric field.
7. The system of claim 1 , wherein the controller is configured to receive input about patient sensations in response to application of the electric field to the target tissue, and to control the electrical signal generator in response to the input about patient sensations to adjust the electric field.
8. The system of claim 1 , wherein the therapeutic effect is for treating at least one condition in a group of conditions comprising chronic pain, acute pain, autonomic disorder, sensory disorder, motor disorder, and cognitive disorder.
9. The system of claim 1 , wherein the therapeutic effect is for treating a chronic pain condition or an acute pain condition.
10. The system of claim 1 , wherein the therapeutic effect comprises a plastic long-term functional change in the target tissue to lessen or eliminate a pathophysiologic disease or syndrome.
11. The system of claim 1 , wherein the target tissue comprises at least one tissue that is within or adjacent to a tissue in a group comprising brain, spinal cord, dorsal root ganglion, sympathetic chain ganglion, cranial nerve, parasympathetic nerve, and peripheral nerve.
12. The system of claim 1 , wherein the target tissue comprises tissue that is within or adjacent to a peripheral nerve comprising at least one of a tibial nerve, a sacral nerve, a sacral nerve plexus, a sacral foramen, and a sciatic nerve.
13. The system of claim 1 , wherein the target tissue comprises a neural tissue.
14. The system of claim 1 , wherein the electrical noise stimulation signal comprises at least one form of noise in a group comprising Gaussian noise, white noise, pink noise, Brownian noise, red noise, and grey noise.
15. The system of claim 1 , wherein the electrical noise stimulation signal has a peak voltage level in the range of about 5V to about 200V and a frequency spectrum in the range of about 100 Hz. to about 750 KHz.
16. A method of using the system of claim 1 , comprising:
implanting the implantable electrode into or near the target tissue of a patient;
implanting the temperature sensor into or near the target tissue of the patient;
applying the electric field from the implantable electrode to the target tissue;
generating the temperature data by the temperature sensor; and
automatically controlling the electrical signal generator by the controller in response to the temperature data to generate the electrical noise stimulation signal to optimize the electric field to produce the therapeutic effect without the temperature data indicating potential damage to the target tissue by the electrical noise stimulation signal.
17. The method of claim 16 , wherein the step of automatically controlling the electrical signal generator comprises reducing a current density or a current flow to the target tissue if the temperature data indicates potential damage to the target tissue.
18. The method of claim 16 , wherein the step of automatically controlling the electrical signal generator comprises reducing a strength of the electric field if the temperature data indicates potential damage to the target tissue.
19. The method of claim 16 , wherein the step of automatically controlling the electrical signal generator comprises limiting a dose of the electric field if the temperature data indicates potential damage to the target tissue.
20. The method of claim 16 , wherein the step of automatically controlling the electrical signal generator comprises controlling the electric field to maximize a voltage of the electric field.
21. The method of claim 16 , including the step of receiving input about sensations of the patient in response to application of the electric field to the target tissue.
22. The system of claim 1 , wherein the temperature sensor is independent of the implantable electrode.
23. A system, comprising:
an electrical signal generator adapted to generate an electrical noise stimulation signal;
an implantable electrode adapted to be implanted into or near a target tissue, wherein the implantable electrode is adapted to receive the electrical noise stimulation signal and to produce an electric field for application to the target tissue;
a temperature sensor adapted to be implanted in or near the target tissue, wherein the temperature sensor is configured to generate a temperature data indicative of a temperature associated with the target tissue in response to application of the electric field to the target tissue; and
a controller in communication with the electrical signal generator and the temperature sensor, wherein the controller is configured to:
receive the temperature data; and
automatically control the electrical signal generator in response to the temperature data to generate the electrical noise stimulation signal that has an optimized electric field with a maximized voltage component to produce a therapeutic effect without the temperature data indicating potential damage to the target tissue by the electrical noise stimulation signal;
wherein the temperature data varies in relation to a level of current density produced by the electric field in the target tissue and wherein optimization of the electric field includes delivering the level of current density that corresponds to a range of temperatures previously determined not to cause damage to the target tissue.
24. The system of claim 23 , wherein the electrical signal generator is adapted to be implantable.
25. The system of claim 23 , wherein the controller is configured to respond to the temperature data indicating the temperature is associated with potential damage to the target tissue by automatically reducing the voltage of the electric field.
26. The system of claim 23 , wherein the controller is configured to control the electrical signal generator to limit a dose of the electric field to produce the therapeutic effect.
27. The system of claim 23 , wherein the controller is configured to receive input about patient sensations in response to application of the electric field to the target tissue, and to control the electrical signal generator in response to the input about patient sensations to adjust the electric field.
28. The system of claim 23 , wherein the therapeutic effect is for treating at least one condition in a group of conditions comprising chronic pain, acute pain, autonomic disorder, sensory disorder, motor disorder, and cognitive disorder.
29. The system of claim 23 , wherein the therapeutic effect is for treating a chronic pain condition or an acute pain condition.
30. The system of claim 23 , wherein the therapeutic effect comprises a plastic long-term functional change in the target tissue to lessen or eliminate a pathophysiologic disease or syndrome.
31. The system of claim 23 , wherein the target tissue comprises at least one tissue that is within or adjacent to a tissue in a group comprising brain, spinal cord, dorsal root ganglion, sympathetic chain ganglion, cranial nerve, parasympathetic nerve, and peripheral nerve.
32. The system of claim 23 , wherein the target tissue comprises tissue that is within or adjacent to a peripheral nerve comprising at least one of a tibial nerve, a sacral nerve, a sacral nerve plexus, a sacral foramen, and a sciatic nerve.
33. The system of claim 23 , wherein the target tissue comprises a neural tissue.
34. The system of claim 23 , wherein the electrical noise stimulation signal comprises at least one form of noise in a group comprising Gaussian noise, white noise, pink noise, Brownian noise, red noise, and grey noise.
35. The system of claim 23 , wherein the electrical noise stimulation signal has a peak voltage level in the range of about 5V to about 200V and a frequency spectrum in the range of about 100 Hz. to about 750 KHz.
36. A method of using the system of claim 23 , comprising:
implanting the implantable electrode into or near the target tissue of a patient;
implanting the temperature sensor into or near the target tissue of the patient;
applying the electric field from the implantable electrode to the target tissue;
generating the temperature data by the temperature sensor; and
automatically controlling the electrical signal generator by the controller in response to the temperature data to generate the electrical noise stimulation signal to optimize the electric field to produce the therapeutic effect without the temperature data indicating potential damage to the target tissue by the electrical noise stimulation signal.
37. The method of claim 36 , wherein the step of automatically controlling the electrical signal generator comprises reducing a current density or a current flow to the target tissue if the temperature data indicates potential damage to the target tissue.
38. The method of claim 36 , wherein the step of automatically controlling the electrical signal generator comprises reducing a strength of the electric field if the temperature data indicates potential damage to the target tissue.
39. The method of claim 36 , wherein the step of automatically controlling the electrical signal generator comprises limiting a dose of the electric field if the temperature data indicates potential damage to the target tissue.
40. The method of claim 36 , wherein the step of automatically controlling the electrical signal generator comprises controlling the electric field to maximize a voltage of the electric field.
41. The method of claim 36 , including the step of receiving input about sensations of the patient in response to application of the electric field to the target tissue.
42. A system, comprising:
an electrical signal generator adapted to generate an electrical noise stimulation signal;
an implantable electrode adapted to be implanted into or near a target tissue, wherein the implantable electrode is adapted to receive the electrical noise stimulation signal from the electrical signal generator and to produce an electric field for application to the target tissue;
a temperature sensor adapted to be implanted in or near the target tissue, wherein the temperature sensor is configured to generate a temperature data indicative of a temperature associated with the target tissue in response to application of the electric field to the target tissue; and
a controller in communication with the electrical signal generator and the temperature sensor, wherein the controller is configured to:
receive the temperature data; and
automatically control the electrical signal generator to reduce a strength of the electric field responsive to the temperature data indicating that the temperature associated with the target tissue is associated with potential damage to the target tissue;
wherein the temperature data varies in relation to a level of current density produced by the electric field in the target tissue and wherein reducing the strength of the electric field includes reducing the level of current density to a level associated with a range of temperatures previously determined not to cause damage to the target tissue.
43. The system of claim 42 , wherein the electrical signal generator is adapted to be implantable.
44. The system of claim 42 , wherein the controller is configured to respond to the temperature data indicating the temperature is associated with potential damage to the target tissue by automatically reducing a voltage of the electric field.
45. The system of claim 42 , wherein the controller is configured to control the electrical signal generator to limit a dose of the electric field to produce a therapeutic effect.
46. The system of claim 42 , wherein the controller is configured to receive input about patient sensations in response to application of the electric field to the target tissue, and to control the electrical signal generator in response to the input about patient sensations to adjust the electric field.
47. The system of claim 42 , wherein the target tissue comprises at least one tissue that is within or adjacent to a tissue in a group comprising brain, spinal cord, dorsal root ganglion, sympathetic chain ganglion, cranial nerve, parasympathetic nerve, and peripheral nerve.
48. The system of claim 42 , wherein the target tissue comprises tissue that is within or adjacent to a peripheral nerve comprising at least one of a tibial nerve, a sacral nerve, a sacral nerve plexus, a sacral foramen, and a sciatic nerve.
49. The system of claim 42 , wherein the target tissue comprises a neural tissue.
50. The system of claim 42 , wherein the electrical noise stimulation signal comprises at least one form of noise in a group comprising Gaussian noise, white noise, pink noise, Brownian noise, red noise, and grey noise.
51. The system of claim 42 , wherein the electrical noise stimulation signal has a peak voltage level in the range of about 5V to about 200V and a frequency spectrum in the range of about 100 Hz. to about 750 KHz.
52. A method of using the system of claim 42 , comprising:
implanting the implantable electrode into or near the target tissue of a patient;
implanting the temperature sensor into or near the target tissue of the patient;
applying the electric field from the implantable electrode to the target tissue;
generating the temperature data by the temperature sensor; and
automatically controlling the electrical signal generator by the controller in response to the temperature data to generate the electrical noise stimulation signal to optimize the electric field without the temperature data indicating potential damage to the target tissue by the electrical noise stimulation signal.
53. The method of claim 52 , wherein the step of automatically controlling the electrical signal generator comprises reducing a current density or a current flow to the target tissue if the temperature data indicates potential damage to the target tissue.
54. The method of claim 52 , wherein the step of automatically controlling the electrical signal generator comprises reducing a strength of the electric field if the temperature data indicates potential damage to the target tissue.
55. The method of claim 52 , wherein the step of automatically controlling the electrical signal generator comprises limiting a dose of the electric field if the temperature data indicates potential damage to the target tissue.
56. The method of claim 52 , wherein the step of automatically controlling the electrical signal generator comprises controlling the electric field to maximize a voltage of the electric field.
57. The method of claim 52 , including the step of receiving input about sensations of the patient in response to application of the electric field to the target tissue.